MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

Dalton, Georgia, December 20, 2025-Shaw Industries has developed a new testing methodology designed to detect perfluoroalkyl and polyfluoroalkyl substances (PFAS) in manufacturing materials, after ...

NI CHESS enables flexible software-driven, lab-based RF validation to reduce costs and risks of field testing.

ViewTech Borescopes, a leading provider of industrial video borescopes, will return as an exhibitor at the Metalcasting ...

Scientists underlined the rising need for advanced diagnostic tools, predictive modelling and integrated assessment ...

Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in ...

Aerospace NDT Market worth $5.69 billion by 2032 - Exclusive Report by MarketsandMarkets (TM) DELRAY BEACH, Fla., April 1, 2026 /PRNewswire/ -- According to MarketsandMarkets (TM), the aerospace NDT ...

The US Army's Nuclear Disablement Teams stand as silent sentinels, expertly safeguarding against nuclear threats.

HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, April 2, 2026 /EINPresswire.com/ -- As global demand for liquefied gas ...

A social media post from the US Food and Drug Administration this week shows a big-eyed macaque staring out from behind bars. “Some drugs use 144 monkeys on average for preclinical testing,” the post ...

March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...

MINNEAPOLIS, MN / ACCESS Newswire / March 12, 2026 / Pace® Analytical Services, the preferred provider of regulatory testing and analytical laboratory services, and a Division of Pace®, a Science and ...